1 – 10 of 121
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Allergen-specific human IgE isolated through an allergen-agnostic pipeline—understanding immune response and allergen recognition
- Contribution to journal › Article
-
Mark
Evaluation of cancer cell membrane-disruption property of poly(vinyl alcohol)–ursodeoxycholic acid using 3D cancer–stromal models with macrophages
- Contribution to journal › Article
-
Mark
Paucity of type 2 cytokines and atypical IL-5 receptor alpha patterns during established eosinophilic inflammation in seasonal allergic rhinitis
- Contribution to journal › Article
- 2025
-
Mark
ATOR-4066, a bispecific antibody targeting CD40 and CEACAM5, induces strong myeloid and T cell-dependent tumor immunity and synergizes with PD-1 blockade
- Contribution to journal › Article
-
Mark
Considerations and Software for Successful Immune Cell Deconvolution Using Proteomics Data
- Contribution to journal › Article
-
Mark
Tumour-infiltrating immune cells in tonsillar cancer : no tissue-level signs of inflammageing in the elderly
- Contribution to journal › Article
- 2024
-
Mark
Fine tuning of the innate and adaptive immune responses by Interleukin-2
- Contribution to journal › Article
-
Mark
IL-2-mediated hepatotoxicity : knowledge gap identification based on the irAOP concept
- Contribution to journal › Article
-
Mark
Next-generation CD40 agonists for cancer immunotherapy
- Contribution to journal › Scientific review
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
- Contribution to journal › Article
